KRTL BioTech

LSE offers no concessions to avert deeper EU probe of Refinitiv deal: sources

LSE offers no concessions to avert deeper EU probe of Refinitiv deal: sources

The London Stock Exchange will not offer concessions to EU antitrust regulators reviewing its $27 billion bid for data and analytics company Refinitiv, two people familiar with the matter said, a move which will likely trigger a four-month probe.